AU1887888A – Human papillomavirus type 41, its DNA and the proteins encoded therefrom
– Google Patents
AU1887888A – Human papillomavirus type 41, its DNA and the proteins encoded therefrom
– Google Patents
Human papillomavirus type 41, its DNA and the proteins encoded therefrom
Info
Publication number
AU1887888A
AU1887888A
AU18878/88A
AU1887888A
AU1887888A
AU 1887888 A
AU1887888 A
AU 1887888A
AU 18878/88 A
AU18878/88 A
AU 18878/88A
AU 1887888 A
AU1887888 A
AU 1887888A
AU 1887888 A
AU1887888 A
AU 1887888A
Authority
AU
Australia
Prior art keywords
human papillomavirus
dna
papillomavirus type
proteins encoded
encoded therefrom
Prior art date
1987-07-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU18878/88A
Other versions
AU617330B2
(en
Inventor
Margitta Grimmel
Ethel-Michele De Villiers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-07-11
Filing date
1988-07-08
Publication date
1989-04-20
1988-07-08
Application filed by Dade Behring Marburg GmbH
filed
Critical
Dade Behring Marburg GmbH
1989-04-20
Publication of AU1887888A
publication
Critical
patent/AU1887888A/en
1991-11-28
Application granted
granted
Critical
1991-11-28
Publication of AU617330B2
publication
Critical
patent/AU617330B2/en
1998-10-29
Assigned to DADE BEHRING MARBURG GMBH
reassignment
DADE BEHRING MARBURG GMBH
Request to Amend Deed and Register
Assignors: BEHRINGWERKE AKTIENGESELLSCHAFT
2008-07-08
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P35/00—Antineoplastic agents
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
C12N15/09—Recombinant DNA-technology
C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
C12Q1/701—Specific hybridization probes
C12Q1/708—Specific hybridization probes for papilloma
G—PHYSICS
G01—MEASURING; TESTING
G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 – G01N31/00
G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
G01N33/56983—Viruses
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00—Medicinal preparations containing peptides
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
C12N2710/00011—Details
C12N2710/20011—Papillomaviridae
C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Abstract
The invention relates to isolation of human papillomavirus type 41, partial characterization of its genome and its cloning in pUC 19. This opens up an access to early diagnosis of skin tumors associated with HPV 41.
AU18878/88A
1987-07-11
1988-07-08
Human papillomavirus type 41, its DNA and the proteins encoded therefrom
Ceased
AU617330B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
DE3722968
1987-07-11
DE19873722968
DE3722968A1
(en)
1987-07-11
1987-07-11
HUMAN PAPILLOMVIRUS TYPE 41, ITS DNA AND THE PROTEINS ENCODING IT
Publications (2)
Publication Number
Publication Date
AU1887888A
true
AU1887888A
(en)
1989-04-20
AU617330B2
AU617330B2
(en)
1991-11-28
Family
ID=6331386
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU18878/88A
Ceased
AU617330B2
(en)
1987-07-11
1988-07-08
Human papillomavirus type 41, its DNA and the proteins encoded therefrom
Country Status (12)
Country
Link
US
(2)
US5142032A
(en)
EP
(1)
EP0301289B1
(en)
JP
(1)
JP2746380B2
(en)
KR
(1)
KR970005047B1
(en)
AT
(1)
ATE111158T1
(en)
AU
(1)
AU617330B2
(en)
CA
(1)
CA1340322C
(en)
DE
(2)
DE3722968A1
(en)
DK
(1)
DK173259B1
(en)
ES
(1)
ES2060625T3
(en)
FI
(1)
FI100538B
(en)
PT
(1)
PT87940B
(en)
Families Citing this family (6)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU699487B2
(en)
*
1993-04-30
1998-12-03
Robert M. Lorence
Methods of treating and detecting cancer using viruses
DE19526386C1
(en)
1995-07-19
1997-01-02
Deutsches Krebsforsch
Papillomaviruses, means for their detection and for the therapy of diseases caused by them
AU778737B2
(en)
*
1999-04-14
2004-12-16
Musc Foundation For Research Development
Tissue-specific and pathogen-specific toxic agents and ribozymes
US20030059806A1
(en)
*
2001-01-05
2003-03-27
Science & Technology Corporation @ Unm
Probes for the detection of human papillomavirus
EP1539245A2
(en)
*
2002-06-26
2005-06-15
The Penn State Research Foundation
Methods and materials for treating human papillomavirus infections
US9376727B2
(en)
2010-05-25
2016-06-28
Qiagen Gaithersburg, Inc.
Fast results hybrid capture assay and associated strategically truncated probes
Family Cites Families (6)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
WO1986005816A1
(en)
*
1985-04-04
1986-10-09
Georgetown University
Type-specific papillomavirus dna sequences and peptides
DE3625257A1
(en)
*
1986-07-23
1988-02-04
Behringwerke Ag
EXPRESSION PRODUCTS OF THE HUMAN PAPILLOMVIRUS TYPE 16 AND 18, FOR THESE PROTEINS, SPECIFIC ANTIBODIES AND THESE ANTIBODIES OR. CORRESPONDING DNA-CONTAINING DIAGNOSTICS
US4849331A
(en)
*
1987-06-09
1989-07-18
Life Technologies, Inc.
Human papillomavirus 44 nucleic acid hybridization probes and methods for employing the same
US4849334A
(en)
*
1987-06-09
1989-07-18
Life Technologies, Inc.
Human papillomavirus 43 nucleic acid hybridization probes and methods for employing the same
DE3722967A1
(en)
*
1987-07-11
1989-01-19
Behringwerke Ag
MONOCLONAL ANTIBODIES AGAINST E7 PROTEIN OF THE HUMAN PAPILLOMVIRUS TYPE 16, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DE3826793A1
(en)
*
1988-08-06
1990-03-08
Behringwerke Ag
HUMAN PAPILLOMVIRUS TYPE 57, ITS DNA AND THE PROTEINS CODED THEREOF
1987
1987-07-11
DE
DE19873722968
patent/DE3722968A1/en
not_active
Withdrawn
1988
1988-07-07
EP
EP88110851A
patent/EP0301289B1/en
not_active
Expired – Lifetime
1988-07-07
AT
AT88110851T
patent/ATE111158T1/en
not_active
IP Right Cessation
1988-07-07
FI
FI883255A
patent/FI100538B/en
not_active
IP Right Cessation
1988-07-07
DE
DE3851391T
patent/DE3851391D1/en
not_active
Expired – Fee Related
1988-07-07
ES
ES88110851T
patent/ES2060625T3/en
not_active
Expired – Lifetime
1988-07-08
US
US07/216,913
patent/US5142032A/en
not_active
Expired – Lifetime
1988-07-08
CA
CA000571554A
patent/CA1340322C/en
not_active
Expired – Fee Related
1988-07-08
AU
AU18878/88A
patent/AU617330B2/en
not_active
Ceased
1988-07-08
PT
PT87940A
patent/PT87940B/en
not_active
IP Right Cessation
1988-07-08
DK
DK198803834A
patent/DK173259B1/en
not_active
IP Right Cessation
1988-07-11
JP
JP63172512A
patent/JP2746380B2/en
not_active
Expired – Fee Related
1988-07-11
KR
KR1019880008579A
patent/KR970005047B1/en
not_active
IP Right Cessation
1993
1993-11-23
US
US08/156,936
patent/US5382509A/en
not_active
Expired – Fee Related
Also Published As
Publication number
Publication date
DE3722968A1
(en)
1989-01-19
EP0301289A1
(en)
1989-02-01
US5382509A
(en)
1995-01-17
FI883255A0
(en)
1988-07-07
AU617330B2
(en)
1991-11-28
CA1340322C
(en)
1999-01-19
KR970005047B1
(en)
1997-04-11
JPS6455182A
(en)
1989-03-02
FI883255A
(en)
1989-01-12
FI100538B
(en)
1997-12-31
JP2746380B2
(en)
1998-05-06
EP0301289B1
(en)
1994-09-07
PT87940B
(en)
1995-03-01
ES2060625T3
(en)
1994-12-01
KR890002402A
(en)
1989-04-10
ATE111158T1
(en)
1994-09-15
DE3851391D1
(en)
1994-10-13
PT87940A
(en)
1989-06-30
DK383488D0
(en)
1988-07-08
US5142032A
(en)
1992-08-25
DK173259B1
(en)
2000-05-29
DK383488A
(en)
1989-01-12
Similar Documents
Publication
Publication Date
Title
FI881736A0
(en)
1988-04-14
Use of beer mash extract for the manufacture of cosmetic products, cosmetic product and beer mash extract
GR3005272T3
(en)
1993-05-24
MY100641A
(en)
1990-12-29
Neutral metalloendopeptidase inhibitors in the treatment of hypertension.
AU579595B2
(en)
1988-12-01
Enzyme-resistant immunomodulatory peptides
EP0853121A3
(en)
1998-08-05
Human DNase
ES8506087A1
(en)
1985-07-01
Preparation of functional human urokinase polypeptides.
AU2001286699A1
(en)
2002-03-04
Nucleic acid and corresponding protein named 158p1h4 useful in the treatment and detection of bladder and other cancers
EP0306219A3
(en)
1990-07-04
Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
NZ505834A
(en)
2002-12-20
Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use
AU617330B2
(en)
1991-11-28
Human papillomavirus type 41, its DNA and the proteins encoded therefrom
AU2174392A
(en)
1993-01-25
Adn sequences of the human papillomavirus type 42, and diagnostic application thereof
AU6493386A
(en)
1987-05-21
Cardiotonic thiazolones
AU3929589A
(en)
1990-02-08
Human papilloma virus type 57, the dna thereof and the proteins encoded thereby
AU2113888A
(en)
1989-02-23
Improvement in or relating to pressure regulating system for use in pressure cookers and pressure cooker having the same
AUPM772494A0
(en)
1994-09-22
Improvements in production of proteins in host cells
CA2271478A1
(en)
1998-05-22
Tissue specific expression of retinoblastoma protein
ES2000594A6
(en)
1988-03-01
Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones.
ES451701A1
(en)
1978-01-01
6{62 ,17-Dihydroxy-7{60 -(lower alkoxy)carbonyl-3-oxo-17{60 -pregn-4-ene-21-carboxylic acid {65 -lactones and congeners
WO2001021653A3
(en)
2001-12-06
Ovarian tumor antigen and methods of use therefor
EP0136093A3
(en)
1986-07-30
Anti-cancer factors
EP0219112A3
(en)
1988-03-23
Cardiotonic aroylthiazolones
Gharavi
1986
Molecular cloning of the human lipoxygenase gene
Rayner
1986
Radical neck dissection for squamous cell carcinoma of the head and neck: Early and long-term results of treatment.
MacPherson
1988
Isolation, characterization and nucleotide sequence of six human tyrosine accepting tRNA genes
EP0278715A3
(en)
1989-03-08
Use of human gamma interferon for treatment of basal cell carcinoma
None